FDA approves new melanoma drug

U.S. regulators on Thursday approved the use of Merck & Co. Inc.'s immuno-oncology drug Keytruda, also known as pembrolizumab, as a treatment for patients with advanced melanoma who are no longer responding to other therapies.

from Health - NY Daily News http://feeds.nydailynews.com/~r/nydnrss/lifestyle/health/~3/BMui3zo2nYU/story01.htm

via nydailynews